Page 57 - Read Online

Page 10 of 11 Silvestri et al. Mini-invasive Surg 2019;3:5 I http://dx.doi.org/10.20517/2574-1225.2018.67

24. Gill IS, Novick AC, Soble JJ, Sung GT, Remer EM, et al. Laparoscopic renal cryoablation: initial clinical series. Urology 1998;52:543-51.
25. Allen BC, Remer EM. Percutaneous cryoablation of renal tumors: patient selection, technique, and postprocedural imaging.
Radiographics 2010;30:887-900.
26. Pan XW, Cui XM, Huang H, Huang Y, Li L, et al. Radiofrequency ablation versus partial nephrectomy for treatment of renal masses: a
systematic review and meta-analysis. Kaohsiung J Med Sci 2015;31:649-58.
27. Olweny EO, Park SK, Tan YK, Best SL, Trimmer C, et al. Radiofrequency ablation versus partial nephrectomy in patients with solitary
clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow up. Eur Urol 2012;61:1156-61.
28. Johnson BA, Sorokin I, Cadeddu JA. Ten-year outcomes of renal tumor radio frequency ablation. J Urol 2019;201:251-8.
29. Pessoa RR, Autorino R, Laguna MP, Molina WR, Gustafson D, et al. Laparoscopic versus percutaneous cryoablation of small renal
mass: systematic review and cumulative analysis of comparative studies. Clin Genitourin Cancer 2017;15:513-9.e5.
30. Zargar H, Atwell TD, Cadeddu JA, de la Rosette JJ, Janetschek G, et al. Cryoablation for small renal masses: selection criteria,
complications, and functional and oncologic results. Eur Urol 2016;69:116-28.
31. Kim EH, Tanagho YS, Saad NE, Bhayani SB, Figenshau RS. Comparison of laparoscopic and percutaneous cryoablation for treatment
of renal masses. Urology 2014;83:1081-7.
32. Atwell TD, Vlaminck JJ, Boorjian SA, Kurup AN, Callstrom MR, et al. Percutaneous cryoablation of stage T1b renal cell carcinoma:
technique considerations, safety, and local tumor control. J Vasc Interv Radiol 2015;26:792-9.
33. Goel RK, Kaouk JH. Probe ablative treatment for small renal masses: cryoablation vs. radio frequency ablation. Curr Opin Urol
2008;18:467-73.
34. Atwell TD, Schmit GD, Boorjian SA, Mandrekar J, Kurup AN, et al. Percutaneous ablation of renal masses measuring 3.0 cm
and smaller: comparative local control and complications after radiofrequency ablation and cryoablation. AJR Am J Roentgenol
2013;200:461-6.
35. Adamy A, Chong KT, Chade D, Costaras J, Russo G, et al. Clinical characteristics and outcomes of patients with recurrence 5 years
after nephrectomy for localized renal cell carcinoma. J Urol 2011;185:433-8.
36. Du Y, Grüllich C, Hadaschik B, Hatiboglu G, Hohenfellner M, et al. Local recurrence after curative surgical treatment of renal cell
cancer: a study of 91 patients. Clin Genitourin 2016;14:e379-85.
37. Guillotreau J, Haber GP, Autorino R. Robotic partial nephrectomy versus laparoscopic cryoablation for the small renal mass. Eur Urol
2012;61:899-904.
38. Capogrosso P, Capitanio U, La Croce G, Nini A, Salonia A, et al. Follow-up after treatment for renal cell carcinoma: the evidence
beyond the guidelines. Eur Urol Focus 2016;1:272-81.
39. Chang SL, Cipriano LE, Harshman LC, Garber AM, Chung BI. Cost-effectiveness analysis of nephron sparing options for the
management of small renal masses. J Urol 2011;185:1591-7.
40. Bhan SN, Pautler SE, Shayegan B, Voss MD, Goeree RA, et al. Active surveillance, radiofrequency ablation, or cryoablation for the
nonsurgical management of a small renal mass: a cost-utility analysis. Ann Surg Oncol 2013;20:3675-84.
41. Badwan K, Maxwell K, Venkatesh R, Figenshau RS, Brown D, et al. Comparison of laparoscopic and percutaneous cryoablation of
renal tumors: a cost analysis. J Endourol 2008;22:1275-7.
42. Link RE, Permpongkosol S, Gupta A, Jarrett TW, Solomon SB, et al. Cost analysis of open, laparoscopic, and percutaneous treatment
options for nephron-sparing surgery. J Endourol 2006;20:782-9.
43. Arnoux V, Descotes JL, Sengel C, Terrier N, Rambeaud JJ, et al. Perioperative outcomes and mid-term results of radiofrequency
ablation and partial nephrectomy in indications of renal tumor treatment and imperative nephron-sparing procedure. Prog Urol
2013;23:99-104.
44. Bensalah K, Zeltser I, Tuncel A, Cadeddu J, Lotan Y. Evaluation of costs and morbidity associated with laparoscopic radiofrequency
ablation and laparoscopic partial nephrectomy for treating small renal tumours. BJU Int 2008;101:467-71.
45. Bird VG, Carey RI, Ayyathurai R, Bird VY. Management of renal masses with laparoscopic-guided radiofrequency ablation versus
laparoscopic partial nephrectomy. J Endourol 2009;23:81-8.
46. Chang X, Liu T, Zhang F, Ji C, Zhao X, et al. Radiofrequency ablation versus partial nephrectomy for clinical T1a renal-cell carcinoma:
long-term clinical and oncologic outcomes based on a propensity score analysis. J Endourol 2015;29:518-25.
47. Chang X, Zhang F, Liu T, Ji C, Zhao X, et al. Radio frequency ablation versus partial nephrectomy for clinical T1b renal cell carcinoma:
long-term clinical and oncologic outcomes. J Urol 2015;193:430-5.
48. Ji C, Zhao X, Zhang S, Liu G, Li X, et al. Laparoscopic radiofrequency ablation versus partial nephrectomy for cT1a renal tumors:
long-term outcome of 179 patients. Urol Int 2016;96:345-53.
49. Kim SH, Lee ES, Kim HH, Kwak C, Ku JH, et al. A propensity-matched comparison of perioperative complications and of chronic kidney
disease between robot-assisted laparoscopic partial nephrectomy and radiofrequency ablative therapy. Asian J Surg 2015;38:126-33.
50. Liu N, Huang D, Cheng X, Chong Y, Wang W, et al. Percutaneous radiofrequency ablation for renal cell carcinoma vs. partial
nephrectomy: comparison of long-term oncologic outcomes in both clear cell and non-clear cell of the most common subtype. Urol
Oncol 2017;35:530.e1-16.
51. Lucas SM, Stern JM, Adibi M, Zeltser IS, Cadeddu JA, et al. Renal function outcomes in patients treated for renal masses smaller than
4 cm by ablative and extirpative techniques. J Urol 2008;179:75-80.
52. Olweny EO, Park SK, Tan YK, Best SL, Trimmer C, et al. Radiofrequency ablation versus partial nephrectomy in patients with solitary
clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up. Eur Urol 2012;61:1156-61.
53. Pantelidou M, Challacombe B, McGrath A, Brown M, Ilyas S, et al. Percutaneous radiofrequency ablation versus robotic-assisted partial
nephrectomy for the treatment of small renal cell carcinoma. Cardiovasc Interv Radiol 2016;39:1595-603.
54. Raman JD, Raj GV, Lucas SM, Williams SK, Lauer EM, et al. Renal functional outcomes for tumours in a solitary kidney managed by
ablative or extirpative techniques. BJU Int 2010;105:496-500.